Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: Expert Opinions on HIV Cure Research
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

U.S. News

WellPoint Will Cover Merck's Gardasil

July 3, 2006

Health insurance company WellPoint Inc. said Thursday it will cover Merck & Co.'s vaccine that blocks the two types of the STD human papillomavirus (HPV) responsible for about 70 percent of cervical cancers. Earlier on Thursday, CDC's Advisory Committee on Immunization Practices recommended the Gardasil vaccine be routinely given to girls ages 11-12. Health officials estimated that more than half of sexually active women and men will be infected with one or more types of HPV in their lifetime. WellPoint said its decision to cover Gardasil was prompted by the committee's recommendation.

Back to other news for July 3, 2006

Adapted from:
Associated Press
06.29.06


  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
See Also
More HIV News

Tools
 

Advertisement